BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26031853)

  • 1. Role of peroxisome proliferator-activated receptor alpha in the expression of hepatic fatty acid oxidation-related genes in chickens.
    Honda K; Saneyasu T; Sugimoto H; Kurachi K; Takagi S; Kamisoyama H
    Anim Sci J; 2016 Jan; 87(1):61-6. PubMed ID: 26031853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines.
    König B; Eder K
    J Nutr Biochem; 2006 Jun; 17(6):410-8. PubMed ID: 16216487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements.
    Song S; Attia RR; Connaughton S; Niesen MI; Ness GC; Elam MB; Hori RT; Cook GA; Park EA
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):54-63. PubMed ID: 20638986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding oxidized fat during pregnancy up-regulates expression of PPARalpha-responsive genes in the liver of rat fetuses.
    Ringseis R; Gutgesell A; Dathe C; Brandsch C; Eder K
    Lipids Health Dis; 2007 Mar; 6():6. PubMed ID: 17352811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
    Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
    J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
    Hsu MH; Savas U; Griffin KJ; Johnson EF
    J Biol Chem; 2001 Jul; 276(30):27950-8. PubMed ID: 11371553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
    Edvardsson U; Ljungberg A; Lindén D; William-Olsson L; Peilot-Sjögren H; Ahnmark A; Oscarsson J
    J Lipid Res; 2006 Feb; 47(2):329-40. PubMed ID: 16282640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
    Regué L; Minichiello L; Avruch J; Dai N
    J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice.
    Erol E; Kumar LS; Cline GW; Shulman GI; Kelly DP; Binas B
    FASEB J; 2004 Feb; 18(2):347-9. PubMed ID: 14656998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.
    Fischer M; You M; Matsumoto M; Crabb DW
    J Biol Chem; 2003 Jul; 278(30):27997-8004. PubMed ID: 12791698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.